Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
AstraZeneca
Express Scripts
Moodys

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for reldesemtiv


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug reldesemtiv?

reldesemtiv is an investigational drug.

There have been 5 clinical trials for reldesemtiv. The most recent clinical trial was a Phase 2 trial, which was initiated on August 16th 2021.

The most common disease conditions in clinical trials are Sclerosis, Motor Neuron Disease, and Amyotrophic Lateral Sclerosis. The leading clinical trial sponsors are Cytokinetics, Astellas Pharma Global Development, Inc., and Astellas Pharma Inc.

There are eight US patents protecting this investigational drug and ninety-five international patents.

Recent Clinical Trials for reldesemtiv
TitleSponsorPhase
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)CytokineticsPhase 3
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)Astellas Pharma IncPhase 2
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)CytokineticsPhase 2

See all reldesemtiv clinical trials

Clinical Trial Summary for reldesemtiv

Top disease conditions for reldesemtiv
Top clinical trial sponsors for reldesemtiv

See all reldesemtiv clinical trials

US Patents for reldesemtiv

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
reldesemtiv ⤷  Try it Free Substituted pyridazines as skeletal muscle modulators CYTOKINETICS, INC. (South San Francisco, CA) ⤷  Try it Free
reldesemtiv ⤷  Try it Free Amino-pyrimidine skeletal muscle modulators Cytokinetics, Inc. (South San Francisco, CA) ⤷  Try it Free
reldesemtiv ⤷  Try it Free Amino-pyrimidine skeletal muscle modulators CYTOKINETICS, INC. (South San Francisco, CA) ⤷  Try it Free
reldesemtiv ⤷  Try it Free Certain amino-pyrimidines, compositions thereof, and methods for their use Cytokinetics, Inc. (South San Francisco, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for reldesemtiv

Drugname Country Document Number Estimated Expiration Related US Patent
reldesemtiv Argentina AR081331 2030-04-23 ⤷  Try it Free
reldesemtiv Argentina AR081626 2030-04-23 ⤷  Try it Free
reldesemtiv Australia AU2011242569 2030-04-23 ⤷  Try it Free
reldesemtiv Australia AU2011242575 2030-04-23 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
AstraZeneca
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.